Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company previously designated 5,852 shares of preferred stock as Series B Convertible Preferred Stock (the “Preferred Stock”).…
Filed Oct 2, 2026Accepted Oct 2, 2026, 5:27 PM EDTCIK 1549084Accession 0001493152-26-045612
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.03Item 5.03 - Amendments to Articles/Bylaws
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
The
Company previously designated 5,852 shares of preferred stock as Series B Convertible Preferred Stock (the “Preferred Stock”).
On
September 29, 2026, the Company filed a Withdrawal of Designation relating to the Preferred Stock (the “Withdrawal of Designation”)
with the Secretary of State of the State of Nevada and terminated the designation of the Preferred Stock. At the time of the filing of
the Withdrawal of Designation, no shares of the Preferred Stock were outstanding. The Withdrawal of Designation was effective upon filing
and eliminated from the Company’s Amended and Restated Articles of Incorporation, as amended, all matters set forth in the previously
filed Certificate of Designation with respect to the previously designated Preferred Stock.
The
foregoing description of the Withdrawal of Designation does not purport to be complete and is qualified in its entirety by reference
to the Withdrawal of Designation, a copy of which is filed as Exhibit 3.1 hereto and which is incorporated herein by reference.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure
Press
Release
On
October 1, 2026, the Company issued a press release announcing the sale of Ekso and the expansion of an agreement with an existing AI
infrastructure customer. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The
information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a filing.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit Description
No.
──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
3.1 Certificate, Amendment or Withdrawal of Designation, relating to the Series B Convertible Preferred Stock, filed with the Secretary of State of Nevada on September 29, 2026.
99.1 Press Release, dated October 1, 2026.
104 Cover
Page Interactive Data File (embedded within the Inline XBRL document).
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm
Exhibit
99.1
Next-Gen
Hybrid AI
ChronoScale
Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
Expanded
agreement with an existing AI infrastructure customer and new customer agreement increases
contracted deployment pipeline and is expected to drive Company annualized revenue run rate
to $1 billion by calendar Q3 2027
ChronoScale
completes previously disclosed sale of Ekso Bionics business unit
MENLO
PARK, Calif., October 1, 2026 (GLOBE NEWSWIRE) - ChronoScale Holdings Corporation (NASDAQ: CHRN) (“ChronoScale”
or the “Company”), an accelerated compute platform purpose-built to support demanding artificial intelligence (AI) workloads,
today announced a significant expansion of an existing customer agreement and a separate agreement with a new customer, that increases
the scale of its contracted AI infrastructure deployments and further strengthens the Company’s contracted revenues.
New
Infrastructure Agreements
ChronoScale
has signed a contract extension with an existing AI infrastructure customer and an agreement with a new AI infrastructure customer. These
two agreements extend the Com…